March 3, 2026Open Access

Medium‐Term Study Results of Ultrasound‐Guided Radiofrequency Ablation for Thyroid Follicular Neoplasm With Low SUV in PET/CT

Key Points

Radiofrequency ablation demonstrates safety and effectiveness for treating follicular neoplasm with low SUVmax.
Patients receiving RFA showed positive medium-term follow-up outcomes, with potential avoidance of surgery.
Assessment of treatment utilized ultrasound guidance for precision in radiofrequency ablation procedures.
Findings suggest that RFA offers a viable option for patients unable to undergo conventional surgery.

Abstract

RFA is a safe and effective treatment for patients with low-risk follicular neoplasm (SUVmax value < 5) in medium-term follow-up. For patients who are either ineligible for or prefer to avoid surgery, RFA presents a feasible alternative treatment option.

Medium‐Term Study Results of Ultrasound‐Guided Radiofrequency Ablation for Thyroid Follicular Neoplasm With Low SUV in PET/CT

Key Points

Abstract

Cite This Study